Next Article in Journal
Genetic Diversity of Pectobacterium spp. on Potato in Serbia
Next Article in Special Issue
Shiga Toxin-Producing Escherichia coli (STEC) Associated with Calf Mortality in Uruguay
Previous Article in Journal
Gut Bacteria and Neurotransmitters
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Characterization of Shiga Toxin Producing Escherichia coli Isolated from Animal Feed in Croatia

by
Marijana Sokolovic
*,
Borka Šimpraga
*,
Tajana Amšel-Zelenika
*,
Marija Berendika
and
Fani Krstulović
Croatian Veterinary Institute, Poultry Centre, Heinzelova 55, 10000 Zagreb, Croatia
*
Authors to whom correspondence should be addressed.
Microorganisms 2022, 10(9), 1839; https://doi.org/10.3390/microorganisms10091839
Submission received: 1 August 2022 / Revised: 11 September 2022 / Accepted: 12 September 2022 / Published: 14 September 2022

Abstract

:
A survey on prevalence and number of Shiga toxin-producing Escherichia (E.) coli (STEC) in animal feed was carried out over a period of nine years in the Republic of Croatia. A total of 1688 feed samples were collected from feed factories and poultry farms. Analysis included two standard procedures: sample enrichment and (a) immunomagnetic separation and plating on two selective media; or (b) plating on two selective media. Confirmation of STEC included morphological examination, biochemical tests, serotyping, and polymerase chain reaction. Morphological and biochemical characterization revealed 629 E. coli strains. Further serological screening method revealed 78 STEC and EPEC serotypes, while only 27 strains were confirmed as STEC with PCR. All positive samples (1.6%) originated from poultry farms and contained combination of virulence genes: eaeA, stx1, and/or stx2. Since the presence of stx (especially stx2) and eae are identified as risk factors for development of severe diseases in humans, results of this survey indicate that avian sources of STEC infections might be one of those “undefined sources” of human illnesses. Further research is necessary for evaluation of risks posed by contaminated feed, poultry, and environment.

1. Introduction

Escherichia (E.) coli is a heterogeneous group, comprising both pathogenic and non-pathogenic strains. Harmless commensals only occasionally (after they acquire additional virulence factors) cause diseases in vulnerable individuals (“YOPI”—young, old, pregnant and immunocompromised individuals). Certain strains are (highly) pathogenic and cause severe diseases in humans and animals [1,2,3,4,5,6,7]. Initially, differentiation of E. coli strains was made with serotyping, biochemical tests, and fermentative patterns. The first antigenic scheme for classification of E. coli, developed by Kauffmann, included 20 somatic (O) antigen groups. Currently, 173 O antigens, 80 K antigens, and 56 H antigens (with further diverging into partial antigens) are described, which gives approximately 50,000–100,000 different E. coli serotypes [8,9,10,11,12]. Although certain serotypes have been implicated in diseases in humans and animals, molecular studies did not confirm clear correlation between genetic relatedness and serotype of E. coli strain [7,13,14]. In addition, occurrence of non-typeable strains indicates that further research should apply several methodologies, especially when strains come from novel environments [15]. Genomes of pathogenic E. coli contain around 500–1000 more genes than the genome of non-pathogenic E. coli strain K12 MG1655 (4566 genes were found in this first complete E. coli genome sequence in 1997). Roughly, 2000 genes are considered common to all E. coli strains. It is considered that pathogenicity relies mainly on the presence of combination of virulence genes that are mainly clustered on pathogenicity islands, within bacteriophages and on plasmids [16,17,18,19,20,21]. Pathogenic E. coli strains are classified into pathotypes of zoonotic intestinal pathogenic E. coli (IPEC) and extraintestinal pathogenic E. coli (ExPEC). The later are associated with extra-intestinal infections (i.e., infections of urinary tract, septicemia, meningitis) in human host, and different diseases in animals (i.e., collibacilosis in poultry). Various serotypes share similar virulence genes (i.e., genes for antimicrobial resistance) between animal and human ExPEC and they can be classified as avian pathogenic E. coli (APEC), neonatal meningitis E. coli (NMEC), and uropathogenic E. coli (UPEC). The IPEC group (or diarrheagenic E. coli (DEC)) strains cause intestinal infections in human host that are characterized by mild to-severe (bloody) diarrhea, hemorrhagic colitis, hemolytic uremic syndrome, and sometimes even death. Six (sub) pathotypes are recognized: diffusely adherent E. coli (DAEC), enteroaggregative E. coli (EAggEC), enteroinvasive E. coli (EIEC), enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), and Shiga-toxin producing (Vero cytotoxin-producing) E. coli (STEC/VTEC), with a subgroup enterohemorrhagic E. coli (EHEC) [17,22,23,24,25,26,27]. The frequent gains and losses of genes due to different factors result in diversification of new strains, and sometimes “hybrid” pathotypes are described. Thus, characterization of strains with specific and/or non-specific combinations of virulence traits enable defining their pathogenic potential [28,29,30].
Shiga-toxin producing E. coli (or verotoxin-producing E. coli) produces one or more toxins (similar to cytotoxins of Shigella dysenteriae) that are known as Shiga toxins (also called Shiga-like toxins or verotoxins). Predominantly, toxins are produced by EHEC (STEC) group. There are two types of Shiga toxin in E. coli: Shiga toxin type 1 (Stx1) (equal to Stx of S. dysneteriae) and Shiga toxin type 2 (Stx2). They both have a number of subtypes (Stx1a, Stx1c, Stc1d, and Stx2a to Stx2g. Stx2h, Stx2i, Stx2k), and (nucleotide) variants (subtype, that differ by one or more amino acids from the prototype). Genes on prophages that are integrated into the chromosome [7,31,32,33] encode toxins. A significantly low dose of infection of STEC (fewer than 100 bacteria, and only ten cells for EHEC) with a short incubation period (2–5 days for E. coli O157:H7) emphasize the pathogenic power of this pathogen. In comparison, EPEC and ETEC infectious dose is ≥108 CFU [34,35]. Mechanism that these pathogens use to invade the host and create an environmental niche for their propagation has been studied extensively. However, certain gaps in understanding still exist. For example, in the initial stage of the infection when the pathogen colonizes the gut, only intimin (94–97 kDA bacterial outer-membrane protein) has been described as the necessary bacterial adhesin for intimate attachment of pathogen to the host epithelial cells and causing “attaching and effacing (A/E)” lesions [36]. There are at least 17 antigenically distinct intimin subtypes [37] encoded by the eae gene and their importance has been documented in a number of infections. Since eae gene has not been detected in all STEC isolates, further research is necessary to elucidate this step of host infection [38,39,40,41]. Besides aforementioned production of Shiga toxins and intimin, there are a great number of additional virulence factors whose role has been studied in STEC infections, including autoagglutinating adhesin (Saa), catalase-peroxidase (katP), long polar fimbrial genes (lpf), plasmid-encoded enterohemolysin (ehxA), subtilase cytotoxin (subAB), and others.
In the latest report on the Zoonoses incidence in 2020 in the European Union, made by the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), STEC infections were the fourth most reported zoonoses in humans, after campylobacteriosis, salmonellosis, and yersiniosis. A decrease in reported cases in 2020 was probably the result of COVID-19 pandemic, since the overall trend for STEC infections has been stable since 2016. The most common sources of human infections were food (meat of different types from different animal species, milk and dairy products and sometimes even fruits, vegetables, and other (not defined) sources). According to the available literature data on potential sources of human STEC infections, ruminants (particularly cattle) are considered as the main reservoir for STEC, while limited evidence exist about (wild) birds and other animals. Among reported serotypes, “top-five” serogroups were the most common (O26, O103, O111, O145, and O157). High rates of prevalence of STEC and diseases in humans have also been reported worldwide [42,43,44,45,46,47].
Since STEC is an important zoonotic pathogen, defining of the source of infection is crucial during outbreak investigations. Furthermore, presence of stx (especially stx2) and eae genes in bacterial strains are considered as risk factors for development of severe diseases in humans and animals. The aim of this research was to evaluate the role of animal feed as a potential source of this pathogen by determination of prevalence of STEC and determination of the presence of stx (and subtypes) and eae genes in isolates.

2. Materials and Methods

2.1. Samples Collection and Isolation of E. coli

In a nine year period (December 2012–November 2021), a total of 1688 feed samples were collected from feed factories and poultry farms situated in eight counties of the Republic of Croatia (Bjelovar-Bilogora County, Koprivnica-Križevci County, Krapina-Zagorje County, Požega-Slavonia, Sisak-Moslavina County, Zagreb County, Varaždin County and The City of Zagreb). All these areas are continental and cover around 30% of the country with around 45% of total population. Majority of feed factories and farms are located in this part of the country. Samples were either tested before use (directly from feed factory), or the samples have already been used for feeding of animals (sampled on poultry farms). Sampling has been done during each month of each year, which enabled determining the potential seasonality of pathogen isolation. Sampling of feed (dry or pelleted feed) to sterile container was made under aseptic conditions. Representative samples (25 g) were prepared according to guidelines for the preparation of test samples from laboratory samples of animal feeding stuffs (EN ISO 6498) and used for analysis. For detection of STEC, we have used two methods. Method (ISO 16654:2001) was employed for detection of E. coli O157:H7 and ISO/TS 13136:2012 method was used for detection of the other non-O157 STEC (Supplementary Materials, Figure S1).
The standard procedure for detection of E. coli O157 (ISO 16654:2001) enables detection of microorganisms that form typical colonies on cefixime tellurite sorbitol MacConkey agar (CT-SMAC) after incubation at 37 °C for 18–24 h. The procedure includes enrichment phase in modified tryptic soy broth (mTSB-N) with novobiocin (20 mg/L) and immunomagnetic separation for capturing E. coli O157 onto immunomagnetic particles (Dynabeads® anti-E. coli O157, Applied Biosystems™, Oslo, Norway), followed by resuspending in 0.1 mL sterile buffer and plating of aliquot (50 µL) of particles/bacteria complex onto Sorbitol McConkey agar supplemented with cefixime tellurite in duplicate (CT-SMAC). Particles were also plated on the second (less) selective media, tryptone bile X-glucuronide agar (TBX). Five suspect sorbitol negative colonies (from CT-SMAC) were tested with confirmatory tests. Likewise, presumptive colonies (up to 50) were selected from TBX agar, pooled and tested with confirmatory tests.
Adapted ISO/TS 13136:2012 was used for detection of other non-O157 STEC. Namely, the standard has been followed without screening part with real-time PCR and all samples were analyzed with culture methods for the presence of non-O157 STEC.

2.2. Characterisation of Isolated E. coli Strains

Confirmatory tests included latex agglutination test (E. coli O157 Latex, Oxoid, France) (detects O157 and H7 antigens), indole test, and API® ID32E (bioMerieux, Marcy-l’Étoile, France). All isolates that were confirmed as E. coli with aforementioned confirmatory tests were plated on non-selective media and serotyped using polyvalent sera (SSI Diagnostica, Denmark, OK O pool 1—STEC/EPEC (O26, O103, O111, O145, and O157), 2—EPEC (O55, O119, O125ac, O127, and O128ab), 3—EPEC (O86, O114, O121, O126, and O142) antisera). The strains that showed agglutination with pool 1 antisera were further tested with monovalent antisera and analyzed by PCR.

2.3. Identification and Characterization of Shiga Toxin-Producing E. coli Genes

Identification and characterization of STEC genes has been done by multiplex PCR method for detection of the main virulence genes: eaeA, stx1, stx2, stx2f (Table 1), according to the method developed by EU Reference Laboratory for E. coli (EURL-VTEC_Method_01_Rev 1) [48].
All strains that contained any of the aforementioned genes were also analyzed with the method that identifies three stx1 subtypes (stx1a, stx1c, and stx1d) and seven stx2 subtypes (stx2a, stx2b, stx2c, stx2d, stx2e, stx2f, and stx2g) by conventional PCR amplification). Shiga toxin producing E. coli (STEC) target genes, their primer sequences, and amplification fragment sizes for stx genes subtyping are presented in Table 2 (EURL-VTEC_Method_006_Rev 2) [48].
For the first method [48], a single bacterial colony was selected from the overnight culture of suspect bacteria on tryptone soy agar (TSA, Oxoid) and suspended in sterilized MilliQ water, boiled for ten minutes. A 50 µL reaction mixture (reaction buffer 1X, MgCl2 1.2 mM, dNTPs 0.2 mM each, 50 pmoles of each primer, 2 Uts of Taq polymerase (Promega) and 10 µL of DNA) was prepared for all samples, as well as for positive and negative control. For testing, we used the Thermal Cycler Biometra T3000 (Analytik Jena, Jena, Germany). Thermal profile included two minutes of initial denaturation and 35 PCR cycles: two minutes of denaturation at 95 °C; two minutes of annealing at 65 °C, decreasing to 60 °C by cycle 15; 1.5 min of elongation at 72 °C, increasing to 2.5 min from cycles 25 to 35, and final extension of three minutes [49]. Afterwards, each reaction mixture (18 µL), molecular weight marker (BenchTop 100 bp DNA ladder Promega ADG8291, Promega Cooperation, Madison, WI, USA), and loading die were loaded in a 2.0% (w/v) agarose gel in TE-buffer (10 mM Tris-HCL, 1 mM EDTA, pH 8) and run at constant voltage (100 V). The gel was stained with ethidium bromide and visualized under UV light. Samples that contained amplification fragments of the specific size (Table 1) were considered as positive for the corresponding target genes.
The second step included subtyping method on all STEC isolates for which the presence of specific genes has already been assessed [48]. We have tested all the strains that show presence of stx1 and/or stx2 group genes. In short, a single bacterial colony was taken from overnight culture on TSA and inoculated in TSB. After overnight incubation, aliquot of 25 µL was mixed with 975 µL MilliQ water in an Eppendorf tube and boiled for 15 min. Afterwards, the samples were centrifuged (22.000 g/5 min) and transferred to a new clean tube. The supernatant was stored at −18 °C for further analyses. For PCR assay, we have prepared reaction mixture of 20 µL and additional 25 µL for triplex PCR. Reaction mixture included five µM of primers and five µL of supernatant of boiled lysate and filled up with MilliQ water to total volume of 20 and 25 µL. We have used HotStart Taq polymerase from Qiagen. Three different amplification conditions were used, each starting with 98 °C for 15 min (HotStart Taq activation) and ending with 72 °C for three minutes. First reaction condition was stx1 subtyping (triplex PCR: 35 cycles at 94 °C for 50 s, 64 °C for 40 s and 72 °C for 60 s), second for stx2a, b, c subtyping (35 cycles at 94 °C for 50 s, 64 °C for 40 s and 72 °C for 60 s), and third for stx2d, e, f, and g subtyping (35 cycles at 94 °C for 50 s, 64 °C for 40 s, and 72 °C for 60 s). For each reaction, we used appropriate positive and negative control. The samples were loaded in 2.0% (w/v) agarose gel in TE-buffer (10 mM Tris-HCL, 1 mM EDTA, pH 8) at quantity of 18 µL of reaction along with loading dye (1X final concentration). The gel was run at a constant voltage (100 V). For evaluation of produced amplicons, we have used molecular weight marker. Visualization of results was made after staining with ethidium bromide under UV light. All procedures have been done using adequate protective equipment. Evaluation of tested isolates included analysis of prevalence of serotypes, seropathotypes, and defining of the discriminatory power of subtyping of STEC with respect to O antigen and corresponding seropathotypes by calculation of Simpson’s index of diversity [50,51].

3. Results

3.1. Isolation and Characterisation of Isolated E. coli Strains

Morphological and biochemical characterization showed the presence of E. coli in 629 (37.3%) feed samples originating from all tested areas in Croatia with a slight seasonal effect (highest in July–August). Further analysis with serological screening method revealed 78 STEC and EPEC serotypes (12.4%) (Figure 1). Despite characteristic growth on selective media and biochemical tests of 551 isolates, they were not confirmed as STEC by using specific antisera and were not further tested with PCR.

3.2. Serotypes and Seropathotypes of Isolated STEC Strains

Among 78 isolated STEC and EPEC serotypes, only 27 samples (4.3% of analyzed strains and 1.60% of all samples tested) were serotyped as positive with OK Pool 1 antisera. All positive samples (n = 27) originated from poultry farms. Remaining 51 isolates gave positive agglutination results with OK Pool 2 (n = 23) and OK Pool 3 (n= 28) antisera. Among 27 STEC-positive isolates, we have detected following serotypes: O26, O103, O111, O121, O145, and O157:H7. Seven isolates did not show agglutination with any of the monovalent sera, although OK Pool 1 reaction was positive (Figure 2).
Seropathotypes (SPT) are defined by Karmali et al. [27] as an approach to classify pathogenic E. coli which have been associated with the onset of human disease. Namely, SPT A has high incidence, it is common in outbreaks, and is associated with HUS or hemorrhagic colitis in humans; SPT B corresponds to moderate incidence, it is uncommon in outbreaks, but is also associated with HUS or hemorrhagic colitis cases in humans; SPT C characterizes low incidence, it is rare in outbreaks, but is also associated with HUS or hemorrhagic colitis in humans. Evaluation of seropathotypes (SPT) of isolated STEC showed that the majority (48%) of isolates belong to SPT B, characterized by moderate incidence, uncommon in outbreaks, but associated with HUS or HC in human hosts. Only 7% belong to SPT A that is characterized with high incidence, common in outbreaks, and associated with HUS or HC in humans (Figure 3).
Evaluation of discriminatory power of subtyping of STEC with respect to O antigen and corresponding seropathotypes isolated in our study was made by calculation of Simpson’s index of diversity. The index, originally developed for the ecological studies of intraspecies populations, is used for determination of the probability that two unrelated strains, sampled from the test population, are placed in different typing groups. The overall serotype diversity in our study was 0.86 for antigen typing method and 0.69 for classification of seropathotypes.

3.3. Virulence Profile of Positive STEC Strains (No = 27)

All isolates that were serotyped positive with OK Pool1, OK Pool2, and OK Pool3 were analyzed by PCR (Table 3). Among 78 isolated strains, only 27 samples (1.60%) harbored at least one of the tested genes (eaeA, stx1, and/or stx2). All positive samples (n = 27) originated from poultry farms. Remaining 51 isolates did not harbor tested genes.

4. Discussion

The importance of animals as a potential source of human infection is evident in the fact that STEC strains (with similar virulence characteristics) have been isolated from human patients, apparently healthy animals, meat, and products thereof. Majority of research on prevalence of STEC in animals and food is focused on ruminants since they are considered as their natural reservoir, although there are several reports on prevalence in other animals and their products [52,53,54]. For example, Bai et al. [55] reported finding of STEC in retail meat samples of pork (4.4%), beef (11.0%), mutton (20.6%), chicken (0.5%), and duck (7.7%), as well as in healthy pigs and yaks. In the latest European Union Zoonoses Report, during 2010–2019, strong-evidence STEC outbreaks were traced to bovine meat and products thereof, water, vegetables and juices, and other products thereof, milk and cheese [56]. In a case of sporadic cases, “strong evidence” was rarely possible to define. Generally, it is observed that STEC contamination of food was 2.5%. When testing fresh meat, the same report showed incidence of STEC in 1.6% of bovine meat, 11.4% of ovine meat, 7.7% of pig meat, and 4.2% in meat from other animal species that included broilers, ducks, wild and farmed game, geese, horses, poultry, rabbits, turkeys, wild boars, and unspecified meat. In animals, observed frequency of STEC was documented for cattle (5.2%), sheep and goats (5.5%), pigs (48%) and other animals that included Cantabrian chamois, deer, wild boar, water buffalo, birds, and foxes (3.2%) with overall incidence of 6.3%. However, all these data should be evaluated as estimates since the number of samples is rather low and applied methodologies are not always comparable. In addition, a number of epidemiological research did not result in defining the source, indicating the need for research on other potential sources of human infections that should also include various animal species including poultry.
Recent finding of pet food positive chicken meat highlights the importance of (re)evaluation of poultry as well as other sources of STEC infections in animals and humans [52]. Furthermore, there is limited information on the detection of STEC and their serogroups in animal feed and especially in feed intended for poultry. Although only a few studies have addressed this issue, number of tested samples and non-comparable methodologies cannot rule out the possibility of feed and avian sources of human infections, especially when poultry meat is still the staple food of many healthy diets. Our results showed low incidence of STEC strains in feed samples derived from poultry farms. Since the sampling strategy was random and did not include additional samples (environment, poultry, personnel) it is difficult to trace the origin of these isolates. However, finding of potentially harmful strains highlights the importance of study at the level of poultry farms. Seasonality of E. coli isolates has already been well documented and it has been described for human STEC illness outbreaks. Although a number of analyzed samples were not equally distributed during the tested time period, we have noticed similar seasonal trend (higher incidence in summer months in our study) as the one that was reported for human illness cases in the EU countries in the period between 2010 and 2020 [43,53,54]. With respect to annual variation, our study shows higher prevalence in the period from 2012 and 2016 year. One potential explanation could be the number of analyzed samples, showing that higher number of analyzed samples yields results that are more precise. On the other hand, it is well-known that E. coli and pathogenic E. coli are widespread in different environments and that they have the ability to persist diverse (un)favorable conditions. A number of different factors including environment, other hosts, and procedures in the feed/food-production-chains might influence the final rates of STEC that we have noticed in our study. Therefore, these results indicate that future research is needed to generate comparable data on (seasonal and annual) prevalence and trends of STEC in feed, animals, and environment.
Incidence of STEC-positive isolates in our study (1.60%, 27 positive of 1688 samples tested) is lower than the reported prevalence of STEC in 2020 in the European Union in fresh meat samples taken from broilers, ducks, wild and farmed game, geese, horses, poultry, rabbits, turkeys, wild boards, and unspecified meat (4.2%, seven positive of 166 samples tested). Since the sample type is not the same, this might explain the noted difference. Previous reports on incidence of STEC in feed and avian sources by other authors show no or rather low incidence (0.5 to 15.56%), although it is not uncommon that avian E. coli harbors stx genes [6,54,55,56,57,58,59,60,61,62,63,64]. Although the STEC prevalence levels in our study and other reports are low, and the fact that only samples from the farm were positive, the transmission of STEC to other birds and environment present a potential risk. Animals are usually asymptomatic carriers making the route of dissemination of pathogens hard to trace. Namely, for some wild birds it has been reported that STEC O157 can be present in their feces for up to 13 days post colonization at the levels above 100 CFU/g and thus transmit infection to other animals and humans. For chickens, up to 11 months of shedding of STEC O157 has been reported [65,66,67].
Growth and survival of pathogenic E. coli in host and environment is influenced by different factors including their abilities to acquire nutrients and energy sources as well as mechanisms that bacteria use to overcome various stressful conditions. Whether environmental fitness of STEC is directly correlated with their pathogenicity can be explained if adaptation mechanisms are investigated along with its gene expression patterns. In addition, persistence in the environment in a form of “dormant” cells maybe does not mean a real threat. However, eliminating the potential sources (animals, feed, food, environment, etc.,) by application of appropriate preventive measures will, at the end, result in a lower risk of infection. Furthermore, it is important to define to what extent can STEC present a threat for infections in human, when poultry industry is in question. Previous research has shown that ruminants are reservoirs while other animals are actually “amplifying hosts”. Presence of STEC in poultry meat points out on poultry as the source. However, it is still not clear what is the relevant contribution and significance of poultry for STEC infection in humans. According to the research of Munghini-Gras et al. [68], estimated contribution of poultry is only 3% but it is not clear whether poultry is the actual host or is it the result of the exposure to contaminated environment. Careful examination of all potential routes of infection (including water, feed, environment and humans) and application of case-control and source attribution analyses would enable proper risk assessment in this area of research.
With respect to serogroups, data are also not completely comparable, since the data on serogroup were not reported for all tested samples (no = 1981) in EU report. Namely, of 54 positive samples, only 11 samples included data on serogroup and those included O6, O8, O104, O11, O145, O146, and O157. Two detected serogroups (O111 and O145) belong to the “top-five” serogroups that are considered responsible for 70–80% of non-O157 STEC produced illnesses. Five serogroups (O8, O111, O145, O146, and O157) detected in this study belong to “top-20” of the most frequent serogroups reported in confirmed cases of human STEC infections and of STEC in food and in animals in the EU in 2020. In our research, four serogroups (O26, O103, O111, and O145) belong to the most common non-O157 serogroups associated with diseases in human in Europe, while O121 and O157 belong to “top-20”. It is interesting to note that the most common non-O157 serogroups in the USA are O26, O45, O103, O111, O121, and O145. Unfortunately, we cannot trace the source of STEC in our samples, nor define impact of feed ingredients and their origin, especially because all the samples originated from Feed Factories were negative. We can only speculate on potential environmental sources or even contact with other animals and/or shedding by asymptomatic workers [47]. In addition, further characterization of the strains with the same serotype is necessary. Therefore, future research will include evaluation of serotypes, virulence factors and defining whether the isolated strains are clonally related.
Similar comparison problem with the data from EFSA’s report is also with virulence profile. Namely, information on virulence profile of STEC isolates was reported only for 13 STEC isolates. Among them, nine were stx2+ and four were stx1+, while eae gene was either negative or this information was also not provided [56]. In our results, all positive STEC isolates harbored at least one tested gene (eaeA, stx1, and/or stx2). However, we have also detected higher incidence of stx2+ genes than stx1+, and presence of eae gene in all STEC-positive isolates. Absence of eae gene in STEC positive strains has been described by other authors, as well as potential loss of specific genes after infection and/or subcultivations [69,70]. Furthermore, presence of eae gene in our strains implicate that they might be more prone to intimate attachment to epithelial host cells and causing “attaching and effacing (A/E)” lesions [36]. According to several authors, evaluation of avian sources of pathogenic E. coli is by defining of EPEC groups. Thus, EPEC was divided into two groups, typical (tEPEC) and atypical (aEPEC) with respect to presence or absence of EPEC adherence factor plasmid (pEAF), respectively. Such strains have also been isolated from avian sources. A number of other features that differentiate those groups have also been described [71,72,73,74]. Following this classification, further research on the presence of EPEC Adherence Factor plasmid and other virulent traits are necessary to evaluate whether there are any relatedness of our strains with the EPEC group. With respect to diversity of isolated STEC in our study, high SDI index for serotyping (0.86) showed high serotype diversity. Taking into account the limits for determination of diversity based on serotyping methods, determination of true diversity can be done using sample-serotype-virulotype profiles. This has also confirmed the importance of simultaneous application of several methodologies, especially in epidemiological studies. Finally, evaluation of poultry as the potential source of STEC strains will be possible only by applying a combination of comparable detection methods and defining the responsible vehicles of infection (with detailed information on contributory factors and source). Evaluation of seropathotypes (SPT), as described previously [27], of isolated STEC showed that 81% (SPTA + SPTB + SPTC) could be associated with human infections such as HUS or HC. Although only 7% belong to SPTA (high incidence and common in outbreaks), feed and/or poultry might be either source or vehicle of potential human infections.

5. Conclusions

Certain serotypes have been implicated in diseases in humans and animals, although molecular studies did not confirm direct correlation between genetic relatedness and serotype of E. coli. Besides defined serotypes and seropathotypes, we have also detected several non-typeable strains for which specific STEC genes were confirmed. Considering the fact that there is a number of other potential virulence traits, as well as the constant emergence of new pathotypes due to the frequent gains and losses of genes, future research needs to include several methodologies, especially when strains come from novel environments. Characterization of isolated STEC strains with specific and/or non-specific combinations of virulence traits, as well as evaluation of other virulence factors will enable defining of their pathogenic potential. Results of this study indicate that avian sources of STEC might be one of those “undefined sources” of human illnesses. Further research will provide necessary data on the role of feed, environment, poultry, and other avian sources in epidemiological studies and aid in evaluation of pathogenic potential of STEC infections in humans and animals.

Supplementary Materials

The following supporting information can be downloaded at: www.mdpi.com/article/10.3390/microorganisms10091839/s1.

Author Contributions

Conceptualization, M.S., B.Š. and T.A.-Z.; methodology, M.S. and B.Š.; software, M.S.; validation, M.S., B.Š., T.A.-Z. and M.B.; formal analysis, M.S., B.Š. and M.B. and F.K.; investigation, M.S., B.Š., M.B. and F.K.; resources, M.S., B.Š. and T.A.-Z.; data curation, M.S., B.Š., T.A.-Z., M.B. and F.K.; writing—original draft preparation, M.S.; writing—review and editing, M.S., B.Š., T.A.-Z., M.B. and F.K.; visualization, M.S.; supervision, project administration, and funding acquisition, M.S., B.Š., T.A.-Z., M.B. and F.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Friedrich, A.W.; Bielaszewska, M.; Zhang, W.L.; Pulz, M.; Kuczius, T.; Ammon, A.; Karch, H. Escherichia coli Harboring Shiga Toxin 2 Gene Variants: Frequency and Association with Clinical Symptoms. J. Infect. Dis. 2002, 185, 74–84. [Google Scholar] [CrossRef] [PubMed]
  2. Beutin, L.; Krause, G.; Zimmermann, S.; Kaulfuss, S.; Gleier, K. Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated from Human Patients in Germany over a 3-Year Period. J. Clin. Microbiol. 2004, 42, 1099–1108. [Google Scholar] [CrossRef] [PubMed]
  3. Persson, S.; Olsen, K.E.P.; Ethelberg, S.; Scheutz, F. Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations. J. Clin. Microbiol. 2007, 45, 2020–2024. [Google Scholar] [CrossRef] [PubMed]
  4. Chaudhuri, R.R.; Henderson, I.R. The Evolution of the Escherichia coli Phylogeny. Infect. Genet. Evol. 2012, 12, 214–226. [Google Scholar] [CrossRef]
  5. Byrne, L.; Vanstone, G.L.; Perry, N.T.; Launders, N.; Adak, G.K.; Godbole, G.; Grant, K.A.; Smith, R.; Jenkins, C. Epidemiology and Microbiology of Shiga Toxin-Producing Escherichia coli Other than Serogroup O157 in England, 2009-2013. J. Med. Microbiol. 2014, 63 Pt 9, 1181–1188. [Google Scholar] [CrossRef]
  6. Morabito, S.; Dell’Omo, G.; Agrimi, U.; Schmidt, H.; Karch, H.; Cheasty, T.; Caprioli, A. Detection and Characterization of Shiga Toxin-Producing Escherichia coli in Feral Pigeons. Vet. Microbiol. 2001, 82, 275–283. [Google Scholar] [CrossRef]
  7. Scheutz, F. Taxonomy Meets Public Health: The Case of Shiga Toxin-Producing Escherichia coli. In Enterohemorrhagic Escherichia coli and Other Shiga Toxin-Producing E. coli; ASM Press: Washington, DC, USA, 2015; pp. 15–36. [Google Scholar] [CrossRef]
  8. Escherich, T. The Intestinal Bacteria of the Neonate and Breast-Fed Infant. 1884. Rev. Infect. Dis. 1988, 10, 1220–1225. [Google Scholar] [CrossRef]
  9. Shiga, K. Ueber Den Disenteriebacillus (Bacillus dysenteriae). Zentralblat fuer Bakteriol. Parasitenkd. und Infekt. Erste Abteilung 1898, 24, 913–918. [Google Scholar]
  10. Kauffmann, F. ZUR SEROLOGIE DER DYSENTERIE-GRUPPE. Acta Pathol. Microbiol. Scand. 1943, 20, 53–78. [Google Scholar] [CrossRef]
  11. Orskov, I.; Orskov, F.; Jann, B.; Jann, K. Serology, Chemistry, and Genetics of O and K Antigens of Escherichia coli. Bacteriol. Rev. 1977, 41, 667. [Google Scholar] [CrossRef]
  12. Orskov, F.; Orskov, I. Escherichia coli Serotyping and Disease in Man and Animals. Can. J. Microbiol. 1992, 38, 699–744. [Google Scholar] [CrossRef] [PubMed]
  13. Caprioli, A.; Scavia, G.; Morabito, S. Public Health Microbiology of Shiga Toxin-Producing Escherichia coli. Microbiol. Spectr. 2014, 2, 245–259. [Google Scholar] [CrossRef] [PubMed]
  14. Naseer, U.; Løbersli, I.; Hindrum, M.; Bruvik, T.; Brandal, L.T. Virulence Factors of Shiga Toxin-Producing Escherichia coli and the Risk of Developing Haemolytic Uraemic Syndrome in Norway, 1992-2013. Eur. J. Clin. Microbiol. Infect. Dis. 2017, 36, 1613–1620. [Google Scholar] [CrossRef]
  15. Erjavec, M.S. The Universe of Escherichia coli [Working Title]; IntechOpen: London, UK, 2019. [Google Scholar] [CrossRef]
  16. Blattner, F.R.; Plunkett, G.; Bloch, C.A.; Perna, N.T.; Burland, V.; Riley, M.; Collado-Vides, J.; Glasner, J.D.; Rode, C.K.; Mayhew, G.F.; et al. The Complete Genome Sequence of Escherichia coli K-12. Science 1997, 277, 1453–1462. [Google Scholar] [CrossRef] [PubMed]
  17. Kaper, J.B.; Nataro, J.P.; Mobley, H.L.T. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004, 2, 123–140. [Google Scholar] [CrossRef] [PubMed]
  18. Schmidt, H.; Hensel, M. Pathogenicity Islands in Bacterial Pathogenesis. Clin. Microbiol. Rev. 2004, 17, 14–56. [Google Scholar] [CrossRef]
  19. Touchon, M.; Hoede, C.; Tenaillon, O.; Barbe, V.; Baeriswyl, S.; Bidet, P.; Bingen, E.; Bonacorsi, S.; Bouchier, C.; Bouvet, O.; et al. Organised Genome Dynamics in the Escherichia coli Species Results in Highly Diverse Adaptive Paths. PLoS Genet. 2009, 5, e1000344. [Google Scholar] [CrossRef]
  20. Gilmore, M.S.; Ferretti, J.J. The Thin Line between Gut Commensal and Pathogen. Science 2003, 299, 1999–2002. [Google Scholar] [CrossRef]
  21. Chapman, T.A.; Wu, X.Y.; Barchia, I.; Bettelheim, K.A.; Driesen, S.; Trott, D.; Wilson, M.; Chin, J.J.C. Comparison of Virulence Gene Profiles of Escherichia coli Strains Isolated from Healthy and Diarrheic Swine. Appl. Environ. Microbiol. 2006, 72, 4782–4795. [Google Scholar] [CrossRef] [Green Version]
  22. Nataro, J.P.; Kaper, J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11, 142–201. [Google Scholar] [CrossRef]
  23. Bélanger, L.; Garenaux, A.; Harel, J.; Boulianne, M.; Nadeau, E.; Dozois, C.M. Escherichia colifrom Animal Reservoirs as a Potential Source of Human Extraintestinal Pathogenic E. coli. FEMS Immunol. Med. Microbiol. 2011, 62, 1–10. [Google Scholar] [CrossRef] [PubMed]
  24. Rivas, L.; Mellor, G.E.; Gobius, K.; Fegan, N. Detection and Typing Strategies for Pathogenic Escherichia coli; Springer Briefs in Food, Health, and Nutrition; Springer: New York, NY, USA, 2015. [Google Scholar] [CrossRef]
  25. Ramos, S.; Silva, V.; de Lurdes Enes Dapkevicius, M.; Caniça, M.; Tejedor-Junco, M.T.; Igrejas, G.; Poeta, P. Escherichia coli as Commensal and Pathogenic Bacteria among Food-Producing Animals: Health Implications of Extended Spectrum β-Lactamase (ESBL) Production. Animals 2020, 10, 2239. [Google Scholar] [CrossRef] [PubMed]
  26. ECDC. Shiga Toxin-Producing Escherichia coli (STEC) Infection—Annual Epidemiological Report for 2019. Available online: https://www.ecdc.europa.eu/en/publications-data/shiga-toxin-producing-escherichia-coli-stec-infection-annual-epidemiological (accessed on 28 July 2022).
  27. Karmali, M.A.; Mascarenhas, M.; Shen, S.; Ziebell, K.; Johnson, S.; Reid-Smith, R.; Isaac-Renton, J.; Clark, C.; Rahn, K.; Kaper, J.B. Association of Genomic O Island 122 of Escherichia coli EDL 933 with Verocytotoxin-Producing Escherichia coli Seropathotypes That Are Linked to Epidemic and/or Serious Disease. J. Clin. Microbiol. 2003, 41, 4930–4940. [Google Scholar] [CrossRef] [PubMed]
  28. Tozzoli, R.; Grande, L.; Michelacci, V.; Ranieri, P.; Maugliani, A.; Caprioli, A.; Morabito, S. Shiga Toxin-Converting Phages and the Emergence of New Pathogenic Escherichia coli: A World in Motion. Front. Cell. Infect. Microbiol. 2014, 4, 80. [Google Scholar] [CrossRef]
  29. Stanford, K.; Reuter, T.; Bach, S.J.; Chui, L.; Ma, A.; Conrad, C.C.; Tostes, R.; McAllister, T.A. Effect of Severe Weather Events on the Shedding of Shiga Toxigenic Escherichia coli in Slaughter Cattle and Phenotype of Serogroup O157 Isolates. FEMS Microbiol. Ecol. 2017, 93, fix098. [Google Scholar] [CrossRef]
  30. Lindstedt, B.A.; Finton, M.D.; Porcellato, D.; Brandal, L.T. High Frequency of Hybrid Escherichia coli Strains with Combined Intestinal Pathogenic Escherichia coli (IPEC) and Extraintestinal Pathogenic Escherichia coli (ExPEC) Virulence Factors Isolated from Human Faecal Samples. BMC Infect. Dis. 2018, 18, 544. [Google Scholar] [CrossRef] [PubMed]
  31. Croxen, M.A.; Law, R.J.; Scholz, R.; Keeney, K.M.; Wlodarska, M.; Finlay, B.B. Recent Advances in Understanding Enteric Pathogenic Escherichia coli. Clin. Microbiol. Rev. 2013, 26, 822–880. [Google Scholar] [CrossRef]
  32. Melton-Celsa, A.R. Shiga Toxin (Stx) Classification, Structure, and Function. Microbiol. Spectr. 2014, 2, 2–4. [Google Scholar] [CrossRef] [Green Version]
  33. Yang, X.; Bai, X.; Zhang, J.; Sun, H.; Fu, S.; Fan, R.; He, X.; Scheutz, F.; Matussek, A.; Xiong, Y. Escherichia coli Strains Producing a Novel Shiga Toxin 2 Subtype Circulate in China. Int. J. Med. Microbiol. 2020, 310, 151377. [Google Scholar] [CrossRef]
  34. Johnson, K.E.; Thorpe, C.M.; Sears, C.L. The Emerging Clinical Importance of Non-O157 Shiga Toxin-Producing Escherichia coli. Clin. Infect. Dis. 2006, 43, 1587–1595. [Google Scholar] [CrossRef]
  35. Mellies, J.L.; Barron, A.M.S.; Carmona, A.M. Enteropathogenic and Enterohemorrhagic Escherichia coli Virulence Gene Regulation. Infect. Immun. 2007, 75, 4199. [Google Scholar] [CrossRef] [PubMed]
  36. Spears, K.J.; Roe, A.J.; Gally, D.L. A Comparison of Enteropathogenic and Enterohaemorrhagic Escherichia coli Pathogenesis. FEMS Microbiol. Lett. 2006, 255, 187–202. [Google Scholar] [CrossRef] [PubMed]
  37. Etcheverría, A.I.; Padola, N.L. Shiga Toxin-Producing Escherichia coli: Factors Involved in Virulence and Cattle Colonization. Virulence 2013, 4, 366–372. [Google Scholar] [CrossRef]
  38. Jerse, A.E.; Yu, J.; Tall, B.D.; Kaper, J.B. A Genetic Locus of Enteropathogenic Escherichia coli Necessary for the Production of Attaching and Effacing Lesions on Tissue Culture Cells (Bacterial Adhesion/Bacterial Pathogenesis/Diarrhea). Proc. Natl. Acad. Sci. USA 1990, 87, 7839–7843. [Google Scholar] [CrossRef] [PubMed]
  39. Donnenberg, M.S.; Tzipori, S.; Mckee, M.L.; O’brien, A.D.; Alroy, J.; Kapert, J.B. The Role of the Eae Gene of Enterohemorrhagic Escherichia coli in Intimate Attachment In Vitro and in a Porcine Model. J. Clin. Investig. 1993, 92, 1418–1424. [Google Scholar] [CrossRef]
  40. Vishram, B.; Jenkins, C.; Greig, D.R.; Godbole, G.; Carroll, K.; Balasegaram, S.; Byrne, L. The Emerging Importance of Shiga Toxin-Producing Escherichia coli Other than Serogroup O157 in England. J. Med. Microbiol. 2021, 70, 001375. [Google Scholar] [CrossRef]
  41. Oswald, E.; Schmidt, H.; Morabito, S.; Karch, H.; Marchès, O.; Caprioli, A. Typing of Intimin Genes in Human and Animal Enterohemorrhagic and Enteropathogenic Escherichia coli: Characterization of a New Intimin Variant. Infect. Immun. 2000, 68, 64–71. [Google Scholar] [CrossRef]
  42. Vally, H.; Hall, G.; Dyda, A.; Raupach, J.; Knope, K.; Combs, B.; Desmarchelier, P. Epidemiology of Shiga Toxin Producing Escherichia coli in Australia, 2000-2010. BMC Public Health 2012, 12, 63. [Google Scholar] [CrossRef] [Green Version]
  43. Majowicz, S.E.; Scallan, E.; Jones-Bitton, A.; Sargeant, J.M.; Stapleton, J.; Angulo, F.J.; Yeung, D.H.; Kirk, M.D. Global Incidence of Human Shiga Toxin-Producing Escherichia coli Infections and Deaths: A Systematic Review and Knowledge Synthesis. Foodborne Pathog. Dis. 2014, 11, 447–455. [Google Scholar] [CrossRef]
  44. Tack, D.M.; Marder, E.P.; Griffin, P.M.; Cieslak, P.R.; Dunn, J.; Hurd, S.; Scallan, E.; Lathrop, S.; Muse, A.; Ryan, P.; et al. Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food—Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2015–2018. MMWR. Morb. Mortal. Wkly. Rep. 2019, 68, 369–373. [Google Scholar] [CrossRef]
  45. Torti, J.F.; Cuervo, P.; Nardello, A.; Pizarro, M. Epidemiology and Characterization of Shiga Toxin-Producing Escherichia coli of Hemolytic Uremic Syndrome in Argentina. Cureus 2021, 13, e17213. [Google Scholar] [CrossRef] [PubMed]
  46. EFSA (European Food Safety Authority). The European Union One Health 2019 Zoonoses Report. EFSA J. 2021, 19, e06406. [Google Scholar] [CrossRef]
  47. EFSA (European Food Safety Authority). Pathogenicity Assessment of Shiga Toxin-Producing Escherichia coli (STEC) and the Public Health Risk Posed by Contamination of Food with STEC. EFSA J. 2020, 18, e05967. [Google Scholar] [CrossRef]
  48. VTEC, E. Laboratory Methods-ISS (EN)-ISS. Available online: https://www.iss.it/web/iss-en/vtec-laboratory-methods (accessed on 28 July 2022).
  49. Paton, A.W.; Paton, J.C. Detection and Characterization of Shiga Toxigenic Escherichia coli by Using Multiplex PCR Assays for Stx1, Stx2, EaeA, Enterohemorrhagic E. coli HlyA, Rfb(O111), and Rfb(O157). J. Clin. Microbiol. 1998, 36, 598–602. [Google Scholar] [CrossRef] [PubMed]
  50. Hunter, P.R.; Gaston, M.A. Numerical Index of the Discriminatory Ability of Typing Systems: An Application of Simpson’s Index of Diversity. J. Clin. Microbiol. 1988, 26, 2465–2466. [Google Scholar] [CrossRef] [PubMed]
  51. Chen, Y.; Brown, E.; Knabel, S.J. Molecular Epidemiology of Foodborne Pathogens. In Genomics of Foodborne Bacterial Pathogens; Springer: Berlin/Heidelberg, Germany, 2011; pp. 403–453. [Google Scholar] [CrossRef]
  52. Treier, A.; Stephan, R.; Stevens, M.J.A.; Cernela, N.; Nüesch-Inderbinen, M. High Occurrence of Shiga Toxin-Producing Escherichia coli in Raw Meat-Based Diets for Companion Animals—A Public Health Issue. Microorganisms 2021, 9, 1556. [Google Scholar] [CrossRef]
  53. Kobayashi, H.; Pohjanvirta, T.; Pelkonen, S. Prevalence and Characteristics of Intimin-and Shiga Toxin-Producing Escherichia coli from Gulls, Pigeons and Broilers in Finland. J. Vet. Med. Sci 2002, 64, 1071–1073. [Google Scholar] [CrossRef] [Green Version]
  54. Mäde, D.; Geuthner, A.C.; Imming, R.; Wicke, A. Detection and Isolation of Shiga-Toxin Producing Escherichia coli in Flour in Germany between 2014 and 2017. J. fur Verbraucherschutz und Leb. 2017, 12, 245–253. [Google Scholar] [CrossRef]
  55. Bai, X.; Wang, H.; Xin, Y.; Wei, R.; Tang, X.; Zhao, A.; Sun, H.; Zhang, W.; Wang, Y.; Xu, Y.; et al. Prevalence and Characteristics of Shiga Toxin-Producing Escherichia coli Isolated from Retail Raw Meats in China. Int. J. Food Microbiol. 2015, 200, 31–38. [Google Scholar] [CrossRef]
  56. EFSA (European Food Safety Authority). The European Union One Health 2020 Zoonoses Report. EFSA J. 2021, 19, e06971. [Google Scholar] [CrossRef]
  57. Sanches, L.A.; Gomes, M.d.S.; Teixeira, R.H.F.; Cunha, M.P.V.; de Oliveira, M.G.X.; Vieira, M.A.M.; Gomes, T.A.T.; Knobl, T. Captive Wild Birds as Reservoirs of Enteropathogenic E. coli (EPEC) and Shiga-Toxin Producing E. coli (STEC). Braz. J. Microbiol. 2017, 48, 760–763. [Google Scholar] [CrossRef] [PubMed]
  58. Pilipčinec, E.; Tkáčiková, L.; Naas, H.T.; Cabadaj, R.; Mikula, I. Isolation of Verotoxigenic Escherichia coli O157 from Poultry. Folia Microbiol. (Praha) 1999, 44, 455–456. [Google Scholar] [CrossRef] [PubMed]
  59. Kariuki, S.; Gilks, C.C.; Kimari, J.; Muyodi, J.; Getty, B.; Hart, C.A. Carriage of Potentially Pathogenic Escherichia coli in Chickens. Avian Dis. 2002, 46, 721–724. [Google Scholar] [CrossRef]
  60. Parreira, V.R.; Gyles, C.L. Shiga Toxin Genes in Avian Escherichia coli. Vet. Microbiol. 2002, 87, 341–352. [Google Scholar] [CrossRef]
  61. Krause, G.; Zimmermann, S.; Beutin, L. Investigation of Domestic Animals and Pets as a Reservoir for Intimin-(Eae) Gene Positive Escherichia coli Types. Vet. Microbiol. 2005, 106, 87–95. [Google Scholar] [CrossRef]
  62. Farooq, S.; Hussain, I.; Mir, M.A.; Bhat, M.A.; Wani, S.A. Isolation of Atypical Enteropathogenic Escherichia coli and Shiga Toxin 1 and 2f-Producing Escherichia coli from Avian Species in India. Lett. Appl. Microbiol. 2009, 48, 692–697. [Google Scholar] [CrossRef]
  63. Lee, G.Y.; Jang, H.I.; Hwang, I.G.; Rhee, M.S. Prevalence and Classification of Pathogenic Escherichia coli Isolated from Fresh Beef, Poultry, and Pork in Korea. Int. J. Food Microbiol. 2009, 134, 196–200. [Google Scholar] [CrossRef]
  64. Alonso, M.Z.; Padola, N.L.; Parma, A.E.; Lucchesi, P.M.A. Enteropathogenic Escherichia coli Contamination at Different Stages of the Chicken Slaughtering Process. Poult. Sci. 2011, 90, 2638–2641. [Google Scholar] [CrossRef]
  65. Xu, J.; Liu, Q.; Jing, H.; Pang, B.; Yang, J.; Zhao, G.; Li, H. Isolation of Escherichia coli O157:H7 from Dung Beetles Catharsius Molossus. Microbiol. Immunol. 2003, 47, 45–49. [Google Scholar] [CrossRef]
  66. Kauffman, M.D.; LeJeune, J. European Starlings (Sturnus Vulgaris) Challenged with Escherichia coli O157 Can Carry and Transmit the Human Pathogen to Cattle. Lett. Appl. Microbiol. 2011, 53, 596–601. [Google Scholar] [CrossRef]
  67. Persad, A.K.; LeJeune, J.T. Animal Reservoirs of Shiga Toxin-Producing Escherichia coli. Microbiol. Spectr. 2014, 2, 211–230. [Google Scholar] [CrossRef] [PubMed]
  68. Mughini-Gras, L.; van Pelt, W.; van der Voort, M.; Heck, M.; Friesema, I.; Franz, E. Attribution of human infections with Shiga toxin-producing Escherichia coli (STEC) to livestock sources and identification of source-specific risk factors, The Netherlands (2010–2014). Zoonoses Public Health 2017, 65, e8–e22. [Google Scholar] [CrossRef] [PubMed]
  69. Karch, H.; Meyer, T.; Russmann, H.; Heesemann, J. Frequent Loss of Shiga-like Toxin Genes in Clinical Isolates of Escherichia coli upon Subcultivation. Infect. Immun. 1992, 60, 3464–3467. [Google Scholar] [CrossRef]
  70. Joris, M.A.; Verstraete, K.; de Reu, K.; de Zutter, L. Loss of Vtx Genes after the First Subcultivation Step of Verocytotoxigenic Escherichia coli O157 and Non-O157 during Isolation from Naturally Contaminated Fecal Samples. Toxins 2011, 3, 672. [Google Scholar] [CrossRef] [PubMed]
  71. Trabulsi, L.R.; Keller, R.; Tardelli Gomes, T.A. Typical and Atypical Enteropathogenic Escherichia coli. Emerg. Infect. Dis. 2002, 8, 508–513. [Google Scholar] [CrossRef]
  72. Hernandes, R.T.; Elias, W.P.; Vieira, M.A.M.; Gomes, T.A.T. An Overview of Atypical Enteropathogenic Escherichia coli. FEMS Microbiol. Lett. 2009, 297, 137–149. [Google Scholar] [CrossRef]
  73. Kaper, J.B.; O’Brien, A.D. Overview and Historical Perspectives. Microbiol. Spectr. 2014, 2, 16. [Google Scholar] [CrossRef] [Green Version]
  74. Adorján, A.; Makrai, L.; Mag, T.; Jánosi, S.; Könyves, L.; Tóth, I. High Frequency of Multidrug-Resistant (MDR) Atypical Enteropathogenic Escherichia coli (AEPEC) in Broilers in Hungary. Front. Vet. Sci. 2020, 7, 511. [Google Scholar] [CrossRef]
Figure 1. Incidence of E. coli and STEC (confirmed at least one strain by detection of stx genes) in analyzed feed samples in a nine-year period (December 2012–November 2021).
Figure 1. Incidence of E. coli and STEC (confirmed at least one strain by detection of stx genes) in analyzed feed samples in a nine-year period (December 2012–November 2021).
Microorganisms 10 01839 g001
Figure 2. Frequency of serotypes of isolated STEC from feed in Croatia during the nine-year period (n = 27 isolates). OK Pool 1: not fully typed, isolates gave positive agglutination with OK Pool 1, but not with individual antisera (n = 7).
Figure 2. Frequency of serotypes of isolated STEC from feed in Croatia during the nine-year period (n = 27 isolates). OK Pool 1: not fully typed, isolates gave positive agglutination with OK Pool 1, but not with individual antisera (n = 7).
Microorganisms 10 01839 g002
Figure 3. Distribution of seropathotypes (SPT) of isolated STEC from feed during the nine-year period (n = 27 strains): SPT A: n = 2; SPT B: n = 13; SPT C: n = 5; Unassigned: not fully typed (n = 7), seropathotypes are defined by Karmali et al. [27].
Figure 3. Distribution of seropathotypes (SPT) of isolated STEC from feed during the nine-year period (n = 27 strains): SPT A: n = 2; SPT B: n = 13; SPT C: n = 5; Unassigned: not fully typed (n = 7), seropathotypes are defined by Karmali et al. [27].
Microorganisms 10 01839 g003
Table 1. Shiga toxin producing E. coli (STEC) target genes, their primer sequences and amplification fragment sizes for multiplex PCR reaction method developed by EU Reference Laboratory for E. coli (EURL-VTEC_Method_01_Rev 1) [48].
Table 1. Shiga toxin producing E. coli (STEC) target genes, their primer sequences and amplification fragment sizes for multiplex PCR reaction method developed by EU Reference Laboratory for E. coli (EURL-VTEC_Method_01_Rev 1) [48].
Target GenePrimer SequenceAmplicon Size (bp)
eaeAeaeAF (GACCCGGCACAAGCATAAGC)
eaeAR (CCACCTGCAGCAACAAGAGG)
384
stx1stx1F (ATAAATCGCCATTCGTTGACTAC)
stx1R (AGAACGCCCACTGAGATCATC)
180
stx2stx2F (GGCACTGTCTGAAACTGCTCC)
stx2R (TCGCCAGTTATCTGACATTCTG)
255
stx2fstx2fF (AGATTGGGCGTCATTCACTGGTTG)
stx2fR (TACTTTAATGGCCGCCCTGTCTCC)
428
Table 2. Shiga toxin producing E. coli (STEC) target genes, their primer sequences and amplification fragment sizes for gene subtyping method developed by EU Reference Laboratory for E. coli (EURL-VTEC_Method_006_Rev 2) [48].
Table 2. Shiga toxin producing E. coli (STEC) target genes, their primer sequences and amplification fragment sizes for gene subtyping method developed by EU Reference Laboratory for E. coli (EURL-VTEC_Method_006_Rev 2) [48].
Target GenePrimer Sequence (5′–3′)Amplicon Size (bp)
stx1
stx1a-F1
stx1a-R2
CCTTTCCAGGTACAACAGCGGTT
GGAAACTCATCAGATGCCATTCTGG
478
stx1c-F1
stx1c-R1
CCTTTCCTGGTACAACTGCGGTT
CAAGTGTTGTACGAAATCCCCTCTGA
252
stx1d-F1
stx1d-R2
CAGTTAATGCGATTGCTAAGGAGTTTACC
CTCTTCCTCTGGTTCTAACCCCATGATA
203
stx2
stx2a-F2
stx2a-R3
stx2a-R2
GCGATACTGRGBACTGTGGCC
CCGKCAACCTTCACTGTAAATGTG
GGCCACCTTCACTGTGAATGTG
349
347
stx2b-F1
stx2b-R1
AAATATGAAGAAGATATTTGTAGCGGC
CAGCAAATCCTGAACCTGACG
251
stx2c-F1
stx2c-R2
GAAAGTCACAGTTTTTATATACAACGGGTA
CCGGCCACYTTTACTGTGAATGTA
177
stx2d-F1
stx2d-R1
stx2d-R2
AAARTCACAGTCTTTATATACAACGGGTG
TTYCCGGCCACTTTTACTGTG
GCCTGATGCACAGGTACTGGAC
179
280
stx2e-F1
stx2e-R2
CGGAGTATCGGGGAGAGGC
CTTCCTGACACCTTCACAGTAAAGGT
411
stx2f-F1
stx2f-R1
TGGGCGTCATTCACTGGTTG
TAATGGCCGCCCTGTCTCC
424
stx2g-F1
stx2g-R1
CACCGGGTAGTTATATTTCTGTGGATATC
GATGGCAATTCAGAATAACCGCT
573
Table 3. Serotypes and virulence profile of isolated STEC in analyzed feed samples in a nine-year period (December 2012–November 2021).
Table 3. Serotypes and virulence profile of isolated STEC in analyzed feed samples in a nine-year period (December 2012–November 2021).
IsolateSerotypeSTEC Target Genes
eaeAstx1stx2
1O26 + -+(stx2a)
2O145++(stx1c)+(stx2a)
3O121+-+(stx2a)
4O111++(stx1a)-
5O103++(stx1a)-
6O111++(stx1a)-
7O157:H7+-+(stx2a, stx2c)
8O26 + -+(stx2a)
9OK Pool 1+-+(stx2a)
10O121+-+(stx2a)
11O26 + -+(stx2a)
12O103++(stx1a)-
13OK Pool 1+-+(stx2a)
14O103++(stx1a)-
15O157:H7+-+(stx2a, stx2c)
16OK Pool 1+-+(stx2a)
17O121+-+(stx2a)
18O103++(stx1a)-
19OK Pool 1+-+(stx2a, stx2c)
20O121+-+(stx2a)
21O26 + +(stx1a)+(stx2a)
22O121+-+(stx2a)
23OK Pool 1+-+(stx2c)
24O103++(stx1a)-
25OK Pool 1+-+(stx2a, stx2c)
26O111++(stx1a)-
27OK Pool 1 + +(stx1a)+(stx2a)
Note: OK Pool 1—if no agglutination was noticed with individual sera.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sokolovic, M.; Šimpraga, B.; Amšel-Zelenika, T.; Berendika, M.; Krstulović, F. Prevalence and Characterization of Shiga Toxin Producing Escherichia coli Isolated from Animal Feed in Croatia. Microorganisms 2022, 10, 1839. https://doi.org/10.3390/microorganisms10091839

AMA Style

Sokolovic M, Šimpraga B, Amšel-Zelenika T, Berendika M, Krstulović F. Prevalence and Characterization of Shiga Toxin Producing Escherichia coli Isolated from Animal Feed in Croatia. Microorganisms. 2022; 10(9):1839. https://doi.org/10.3390/microorganisms10091839

Chicago/Turabian Style

Sokolovic, Marijana, Borka Šimpraga, Tajana Amšel-Zelenika, Marija Berendika, and Fani Krstulović. 2022. "Prevalence and Characterization of Shiga Toxin Producing Escherichia coli Isolated from Animal Feed in Croatia" Microorganisms 10, no. 9: 1839. https://doi.org/10.3390/microorganisms10091839

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop